Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
St. Louis Public Radio (NPR) Spotlights OCRA’s Survivors Teaching Students Program
OCRA’s Survivors Teaching Students® (STS) program was recently highlighted on St. Louis Public Radio’s St. Louis on the Air in an episode titled “How Ovarian Cancer Survivors are Helping Educate … Continued
The Overview: November 2024
International Forum on Ovarian Cancer Aims to Accelerate Progress Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and … Continued
OCRA Joins Global Leaders to Propel Ovarian Cancer Research Forward at HHMT Conference
Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at … Continued